Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain

被引:27
|
作者
Gonzalez-Escalada, Alba [1 ,2 ]
Garcia-Garcia, Laura [1 ,2 ]
Viguera-Ester, Pablo [1 ,2 ]
Marin-Garcia, Patricia [1 ,2 ]
Garcia, Jesus [3 ]
Gil-de-Miguel, Angel [1 ,2 ]
Gil-Prieto, Ruth [1 ,2 ]
机构
[1] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Madrid, Spain
[2] Univ Rey Juan Carlos, Dept Immunol & Med Microbiol, Madrid, Spain
[3] Fuenlabrada Univ Hosp, Microbiol Unit, Madrid, Spain
关键词
seroprevalence; young adults; measles; rubella; mumps; B; Pertussis; Varicela-Zoster Virus; BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; VIRUS; POPULATION; CATALONIA; COUNTRIES; ASSAYS; STANDARDIZATION; EPIDEMIOLOGY; PERFORMANCE;
D O I
10.4161/hv.25127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In recent years, there has been an increase in the number of cases of certain immunopreventable diseases in our country. A high proportion of these have been recorded among the young adult population. The aim of this study was to determine the seroprevalence of antibodies against immunopreventable diseases with the greatest health impacts on the young adult population (19-39 y of age) in Madrid. We collected a total of 1,153 serum samples from healthy volunteers undergoing routine medical visits and used ELISA to determine the presence of IgG antibodies against measles, rubella, mumps, and varicella zoster, as well as Bordetella pertussis. The Pearson's 2 test was used to compare prevalences, the Mann-Whitney U test was used to compare means, and the Kruskal-Wallis test was applied for variables with more than 2 categories. Statistical significance was achieved with p values of < 0.05. The global prevalence of antibodies was 92.1% for measles, 94.4% for rubella, 88.3% for mumps, 92.8% for varicella zoster, and 70.2% for B. pertussis. No statistically significant differences were found between genders. The prevalence of antibodies against measles was more than 95% in the group of individuals born after 1986, and the percentage of individuals susceptible to rubella was less than 5% in women born after 1986. In spite of adequate vaccination coverage, in our region, a population of young adults exists who have not achieved the objectives of the WHO for the elimination of measles and congenital rubella syndrome.
引用
收藏
页码:1918 / 1925
页数:8
相关论文
共 50 条
  • [11] Vaccines for Measles, Mumps, Rubella, Varicella, and Herpes Zoster: Immunization Guidelines for Adults
    Hendriksz, Tami
    Malouf, Philip
    Foy, James E.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (10): : S10 - S12
  • [12] Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer
    Bochennek, Konrad
    Allwinn, Regina
    Langer, Rebecca
    Becker, Martina
    Keppler, Oliver T.
    Klingebiel, Thomas
    Lehrnbecher, Thomas
    VACCINE, 2014, 32 (27) : 3357 - 3361
  • [13] Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay
    Dhiman, Neelam
    Jespersen, Deborah J.
    Rollins, Leonard O.
    Harring, Julie A.
    Beito, Elaine M.
    Binnicker, Matthew J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 67 (04) : 346 - 349
  • [14] Performance evaluation of the bio-rad BioPlex 2200 multiplex system in the detection of measles, mumps, rubella, and varicella-zoster antibodies
    Lafreniere, Matthew A.
    Badr, Eley
    Beattie, John
    Macri, Joseph
    Khan, Waliul I.
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2023, 3 (01):
  • [15] Development of a Bead-Based Multiplex Immunoassay for Simultaneous Quantitative Detection of IgG Serum Antibodies against Measles, Mumps, Rubella, and Varicella-Zoster Virus
    Smits, Gaby P.
    van Gageldonk, Pieter G.
    Schouls, Leo M.
    van der Klis, Fiona R. M.
    Berbers, Guy A. M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (03) : 396 - 400
  • [16] Measles, rubella and varicella-zoster (MRZ) viral antibodies in CSF of spanish MS patients
    Fernandez, Manuel Miguel Guerrero
    Sorlozano, Antonio
    Serrano, Carmen
    Gutierrez, Jose
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 893 - 894
  • [17] Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009-2010
    Lebo, Emmaculate J.
    Kruszon-Moran, Deanna M.
    Marin, Mona
    Bellini, William J.
    Schmid, Scott
    Bialek, Stephanie R.
    Wallace, Gregory S.
    McLean, Huong Q.
    OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (01):
  • [18] Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women
    Hanaoka, Masachi
    Hisano, Michi
    Watanabe, Noriyoshi
    Sugawara, Kana
    Kambe, Yukari
    Kanda, Eriko
    Sago, Haruhiko
    Kato, Tatsuo
    Yamaguchi, Koushi
    VACCINE, 2013, 31 (19) : 2343 - 2347
  • [19] Incidence of herpes zoster and seroprevalence of varicella-zoster virus in young adults of South Korea
    Kang, Cheol-In
    Choi, Chang-Min
    Park, Tae-Sung
    Lee, Dong-Jun
    Oh, Myoung-don
    Choe, Kang-Won
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (03) : 245 - 247
  • [20] Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness
    Odemis, Ilker
    Kose, Sukran
    Akbulut, Ilkay
    Albayrak, Hazal
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (06) : 525 - 531